(2008) The Nrf2-ARE pathway: an indicator and modulator of oxidative stress in neurodegeneration
Plus Orlistat and Phentermine, the drugs DSS is seeking federal approval for, while cheaper, are much less effective at treating obesity and have more severe side effects, Toubman said
Cell Metab 2017;25:1045-1053
(More on these below.) Evaluate lifestyle factors
Holman RR, Bethel MA, Chan JC, Chiasson JL, Doran Z, Ge J, Gerstein H, Huo Y, McMurray JJ, Ryden L, Liyanage W, Schrder S, Tendera M, Theodorakis MJ, Tuomilehto J, Yang W, Hu D, Pan C, ACE Study Group
ACHIEVE-5 (NCT06109311) A placebo-controlled trial in type 2 diabetes, complementing the active comparator studies by providing clean placebo-adjusted efficacy estimates